FIELD: medicine.
SUBSTANCE: invention claims compounds of the formula , where R1, R2, R3 and R4 are equal or different, and each element is oxo group, hydroxy group, mercapto group, hydrogen atom, halogen atom, alcoxy group or aryloxy group, and dot line shows possible simple or double link between one or respective hydrogen atom pairs; and their complex ethers, which can be injected transcutaneously.
EFFECT: most efficient application in plaster form, preferably with adhesive substance containing copolymer of 40-60 wt % of metoxyethylacrylate, 30-40 wt % of laurylacrylate or laurylmethylacrylate and 10-25 wt % of polar monomer.
18 cl, 7 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
DEVICE FOR TRANSDERMAL BISOPROLOL INTRODUCTION | 2008 |
|
RU2440811C2 |
TRANSDERMAL PLASTER FOR FENTANYL INTRODUCTION | 2007 |
|
RU2351318C2 |
TRANSDERMAL PATCH FOR ADMINISTERING FENTANYL | 2002 |
|
RU2657397C2 |
TRANSDERMAL PLASTER FOR ADMINISTRATION OF FENTANYL | 2002 |
|
RU2301059C2 |
RUPATADINE-CONTAINING PATCH | 2018 |
|
RU2776063C2 |
TRANSDERMAL PATCH FOR ADMINISTERING FENTANYL | 2002 |
|
RU2708563C2 |
TETRABENAZINE TRANSDERMAL DELIVERY DEVICE | 2019 |
|
RU2800536C2 |
TRANSDERMAL DONEPEZIL DELIVERY SYSTEM | 2017 |
|
RU2779471C2 |
TRANSDERMALLY ABSORBABLE FORMULATION CONTAINING DONEPEZIL | 2010 |
|
RU2545696C2 |
METHOD FOR MAKING PREPARATION FOR TRANSDERMAL NICOTINE INTRODUCTION | 2006 |
|
RU2403018C2 |
Authors
Dates
2009-10-27—Published
2005-04-28—Filed